Drug Target Analysis in the Human Central Nervous System

Closed Solicitation Posted

Solicitation number
FDASB75F40124Q00344
Agency
Responses due
Set-aside
Total Small Business

Opportunity facts

Notice details come from SAM.gov. Updated .

About this opportunity

The Department of Health and Human Services (HHS), Food and Drug Administration (FDA), through its National Center for Toxicological Research (NCTR), is seeking protein binding and functional assay services to identify and verify drug targets associated with adverse neuropsychiatric effects. The services must analyze over 14 protein targets/receptors and provide binding, calcium flux, cAMP, and v-arrestin data in either agonist or antagonist formats. The analysis must be completed within 30 days after receipt of the test article, and the data provided in Excel and/or PDF formats. This is a one-time analysis, with no option periods.

This solicitation is set aside for small businesses under NAICS code 541714 - Research and Development in Biotechnology (except Nanobiotechnology). Quotes are due by 1:00 PM Central Time on July 7, 2024 and must be FOB Destination inclusive of all charges. The evaluation criteria are not specified, but the government is seeking to procure these services at the best value.

Notice text

Questions are due 08/28/2024 at noon 

Proposals are due 09/02/2024 at noon 

Files

File Type Posted
SB- RFQ-75F40124Q00344.pdf PDF

Similar open opportunities

Opportunity Agency Set-aside Responses due
Senior Advisor Subject Matter Expert (SME) with Pharmaceutical Development and Pain Expertise for the NINDS Bethesda, Maryland 20892, United States · NAICS 541690 Office of the Assistant Secretary for Administration Total Small Business
Tau radiotracers for Baltimore Longitudinal Study of Aging United States · NAICS 325414 National Institute on Drug Abuse No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity